Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma

Cancer

Volumn 118, Issue 4, 2012, Pages 1040-1047

  Erman, Audrey B ^a   Collar, Ryan M ^a   Griffith, Kent A ^b   Lowe, Lori ^a   Sabel, Michael S ^a   Bichakjian, Christopher K ^a   Wong, Sandra L ^a   McLean, Scott A ^a   Rees, Riley S ^a   Johnson, Timothy M ^a   Bradford, Carol R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

accuracy; cutaneous; head and neck; melanoma; prognosis; sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HAZARD RATIO; HEAD AND NECK CANCER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MELANOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TUMOR LOCALIZATION; CANCER LOCALIZATION; CANCER RECURRENCE; HEAD AND NECK MELANOMA; LYMPH NODE DISSECTION; PROSPECTIVE STUDY; SENTINEL LYMPH NODE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; INFANT; LYMPH NODE EXCISION; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84856801902     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26288     Document Type: Article

References (43)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992; 127: 392-399.
2. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009; 27: 6199-6206.
3. O'Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg. 1995; 170: 461-466.
4. Willis AI, Ridge JA,. Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head Neck. 2007; 29: 979-985.
5. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005; 242: 302-311.
6. Chao C, Wong SL, Edwards MJ, et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol. 2003; 10: 21-26.
7. Carlson GW, Page AJ, Cohen C, et al. Regional recurrence after negative sentinel lymph node biopsy for melanoma. Ann Surg. 2008; 248: 378-386.
8. Saltman BE, Ganly I, Patel SG, Coit DG, Brady MS, Wong RJ,. Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma. Head Neck. 2010; 32: 1686-1692.
9. Leong SP, Accortt NA, Essner R, et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg. 2006; 132: 370-373.
10. Gomez-Rivera F, Santillan A, McMurphey AB, et al. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study. Head Neck. 2008; 30: 1284-1294.
11. Paek SC, Griffith KA, Johnson TM, et al. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer. 2007; 109: 100-108.
12. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH,. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med. 1993; 34: 1435-1440.
13. Schmalbach CE, Nussenbaum B, Rees RS, Schartz J, Johnson TM, Bradford CR,. Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg. 2005; 129: 61-65.
14. National Comprehensive Cancer Network. Cancer references and guidelines. Available at: Accessed January 2011.
15. Karimpour DJ, Lowe L, Su L, et al. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful? J Am Acad Dermatol. 2004; 50: 759-764.
16. McMasters KM, Reitgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol. 2001; 8: 192-197.
17. va der Ploeg AP, van Akkooi AC, Schmitz PI, Koljenovic S, Verhoef C, Eggermont AM,. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria. Eur J Cancer. 2010; 46: 2414-2421.
18. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006; 355: 1307-1317.
19. Nowecki ZI, Rutkowski P,Nasierowska-Guttmejer, Ruka W,. Analysis and clinicopathologic factors associated with false negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol. 2006; 13: 1655-1663.
20. Carlson GW, Murray DR, Lyles RH, Hestlet A, Cohen C,. Sentinel lymph node biopsy in the management of cutaneous head and neck melanoma. Plast Reconstr Surg. 2005; 115: 721-728.
21. Telztrow T, Osinga J, Schwipper V,. Reliability of sentinel-node extirpation as a diagnostic method for malignant melanoma of the head and neck region. Int J Maxillofac Surg. 2007; 35: 481-487.
22. DeWilt JH, Thompson JF, Uren RF, et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg. 2004; 239: 544-552.
23. Doting EH, de Vries M, Plukker JT, et al. Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome? J Surg Oncol. 2006; 93: 564-570.
24. Kelly J, Fogarty K, Redmond HP,. A definitive role for sentinel lymph node mapping with biopsy for cutaneous melanoma of the head and neck. Surgeon. 2009; 6: 336-339.
25. Shiptzer T, Segal K, Schachter J, et al. Sentinel node guided surgery for melanoma in the head and neck region. Melanoma Res. 2004; 14: 283-287.
26. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg. 1999; 230: 453-463.
27. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001; 19: 3622-3634.
28. Patel SG, Coit DG, Shaha AR, et al. Sentinel lymph node biopsy for cutaneous head and neck melanomas. Arch Otolaryngol Head Neck Surg. 2002; 128: 285-291.
29. Picon AI, Colt AR, Brady MS, et al. Sentinel lymph node biopsy for cutaneous head and neck melanoma: mapping the parotid gland. Ann Surg Oncol. [published online May 23, 2006.]
30. Loree TR, Tomljanovich PI, Cheney RT, Hicks WL, Rigual NR,. Intraparotid sentinel lymph node biopsy for head and neck melanoma. Laryngoscope. 2006; 116: 1461-1464.
31. Ollila DW, Foshag LJ, Essner R, Stern SL, Morton DL,. Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma. Ann Surg Oncol. 1999; 6: 150-154.
32. Bostick P, Essner S, Kelley M,. Intraoperative mapping for early-stage melanoma of the head and neck. Am J Surg. 1997; 174: 536-539.
33. Wells KE, Rapaport DP, Cruse CW,. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg. 1997; 100: 591-594.
34. Carlson GW, Murray DR, Greenlee R,. Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg. 2000; 126: 433-437.
35. Jansen L, Koops HS, Nieweg OE,. Sentinel lymph node biopsy for melanoma in the head and neck region. Head Neck. 2000; 22: 27-33.
36. Wagner JD, Park HM, Coleman JJ III, Love C, Hayes JT,. Cervical lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg. 2000; 126: 313-321.
37. Medina-Franco H, Beenken SW, Heslin MJ, Urist MM,. Sentinel node biopsy for cutaneous melanoma in the head and neck. Ann Surg Oncol. 2001; 8: 716-719.
38. Schmalbach CE, Nussenbaum B, Rees RS, Schwartz J, Johnson TM, Bradford CR,. Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg. 2003; 129: 61-65.
39. MacNeill KN, Ghazarian D, McCready D, Rotstein L,. Sentinel lymph node biopsy for cutaneous melanoma of the head and neck. Ann Surg Oncol. 2005; 12: 726-732.
40. Lin D, Franc BL, Kashani-Sabert M, Singer MI,. Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy. Head Neck. 2006; 28: 249-255.
41. Kilpatrick LA, Shen P, Stewart JH, Levine EA,. Use of sentinel node biopsy for melanoma of the head and neck. Ann Surg. 2007; 73: 754-758.
42. Agnese DM, Maupin R, Tillman B, Pozderac RD, Margo C, Walker MJ,. Head and neck melanoma in the sentinel lymph node era. Arch Otolaryngol Head Neck Surg. 2007; 133: 1121-1124.
43. Koskivuo IO, Kinnunen IA, Suominen EA, Vihinen PP, Grenman RA,. Head and neck cutaneous melanoma: a retrospective observational study on 146 pateints. Acta Oncol. 2009; 48: 460-467.